Use of sEH inhibitors as analgesics
View Patent ↗The present invention provides methods and compositions for relieving pain and itching, of promoting wound healing, of reducing sickness behavior and of reducing inflammatory bowel disease or acne lesions in a subject by the topical administration of an inhibitor of soluble epoxide hydrolase, or of a cis-epoxyeicosatrienoic acid (“EET”), or by both.
1. A method of relieving neuropathic pain in a subject, said method comprising topically administering to said subject an effective amount of an inhibitor of soluble epoxide hydrolase (“sEH”), thereby relieving neuropathic pain in said subject, wherein the inhibitor of sEH has a pharmacophore that is a urea, a carbamate or an amide.
2. A method of claim 1 , wherein the pain relieved is from a burn.
3. A method of claim 1 , wherein the pain is from post-herpetic neuralgia.
4. A method of claim 1 , further comprising topically administering an epoxide of a polyunsaturated fatty acid.
5. A method of claim 4 , wherein said epoxide is a cis-epoxyeicosatrienoic acid (“EET”).
6. A method of claim 5 , wherein said EET is selected from the group consisting of 5,6-EET, 14,15-EET, 8,9-EET, and 11,12-EET.
7. A method of claim 1 , wherein said subject does not have hypertension, or is not being treated for hypertension with an inhibitor of sEH.
8. A method of claim 1 , wherein said inhibitor of sEH is administered to an area of skin one hour or less before a dermatological procedure or cosmetic surgery on said area of skin to relieve pain associated with said procedure or surgery.
9. A method of claim 1 , wherein said topical administration is by a suppository comprising said inhibitor of sEHI.
10. A method of claim 1 , wherein said inhibitor of sEH inhibits sEH with an IC50 of less than about 500 μM.
11. A method of claim 1 , wherein the pain relieved is pain in the extremities from diabetic neuropathy.